The Ate-Grab-treated group, which exhibited decreased tumor fibrosis (Fig. 4d, e), had greater NG2+ or PDGFRβ+ pericyte coverage (Fig. 4g, h and Supplementary Fig. 4b, c). The gene discussed is PDGFRB; the disease is neoplasm.